All In Biotech

Drug Trial Radar · NCT07899073

A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients

A Multicenter, Randomized, Double-blind, Phase Ⅲ Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 225 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

225

Planned (sponsor's estimate)

Start

Oct 2026

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Sponsor type
Industry
First posted
Oct 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 19 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Multicenter, Randomized, Double-blind, Phase Ⅲ Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients

Conditions

  • Erectile Dysfunction

Interventions

  • HIP2602 + HPP2602-2Drug

    Test drug

  • HPP2602-1 + HPP2602-2Drug

    Control drug

  • HGP1201 + HPP2602-1Drug

    Active Comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of IIEF-EF domain score from baseline after 12 weeksTime frame: baseline, 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pusan National University Hospital

    Busan, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.